Literature DB >> 23611952

Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.

Qi Yin1, Jianan Shen, Zhiwen Zhang, Haijun Yu, Yaping Li.   

Abstract

Multidrug resistance (MDR) is a major obstacle to successful cancer therapy, especially for chemotherapy. The new drug delivery system (DDS) provides promising approaches to reverse MDR, for which the poor cellular uptake and insufficient intracellular drug release remain rate-limiting steps for reaching the drug concentration level within the therapeutic window. Stimulus-coupled drug delivery can control the drug-releasing pattern temporally and spatially, and improve the accumulation of chemotherapeutic agents at targeting sites. In this review, the applications of DDS which is responsive to different types of stimuli in MDR cancer therapy is introduced, and the design, construction, stimuli-sensitivity and the effect to reverse MDR of the stimuli-responsive DDS are discussed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Drug delivery; Multidrug resistance; Responsive; Stimuli; Tumor

Mesh:

Substances:

Year:  2013        PMID: 23611952     DOI: 10.1016/j.addr.2013.04.011

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  44 in total

1.  Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.

Authors:  Feng-Qian Chen; Jin-Ming Zhang; Xie-Fan Fang; Hua Yu; Yu-Ling Liu; Hui Li; Yi-Tao Wang; Mei-Wan Chen
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

Review 2.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

3.  A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.

Authors:  Mingzhen Zhang; Changlong Xu; Liuqing Wen; Moon Kwon Han; Bo Xiao; Jun Zhou; Yuchen Zhang; Zhan Zhang; Emilie Viennois; Didier Merlin
Journal:  Cancer Res       Date:  2016-10-14       Impact factor: 12.701

Review 4.  Application of chitosan-based nanocarriers in tumor-targeted drug delivery.

Authors:  Mohammad Ali Ghaz-Jahanian; Farzin Abbaspour-Aghdam; Navideh Anarjan; Aydin Berenjian; Hoda Jafarizadeh-Malmiri
Journal:  Mol Biotechnol       Date:  2015-03       Impact factor: 2.695

5.  Weak Bond-Based Injectable and Stimuli Responsive Hydrogels for Biomedical Applications.

Authors:  Xiaochu Ding; Yadong Wang
Journal:  J Mater Chem B       Date:  2016-12-16       Impact factor: 6.331

6.  A large-inner-diameter multi-walled carbon nanotube-based dual-drug delivery system with pH-sensitive release properties.

Authors:  Tao Yang; Zhenzhen Wu; Pingting Wang; Tingting Mu; Han Qin; Zhimin Zhu; Jian Wang; Lei Sui
Journal:  J Mater Sci Mater Med       Date:  2017-06-06       Impact factor: 3.896

Review 7.  Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriers.

Authors:  Jian-Ping Liu; Ting-Ting Wang; Dang-Ge Wang; An-Jie Dong; Ya-Ping Li; Hai-Jun Yu
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

8.  Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.

Authors:  Cong Luo; Jin Sun; Dan Liu; Bingjun Sun; Lei Miao; Sara Musetti; Jing Li; Xiaopeng Han; Yuqian Du; Lin Li; Leaf Huang; Zhonggui He
Journal:  Nano Lett       Date:  2016-08-08       Impact factor: 11.189

9.  Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.

Authors:  Cong Luo; Jin Sun; Bingjun Sun; Dan Liu; Lei Miao; Tyler Jay Goodwin; Leaf Huang; Zhonggui He
Journal:  Small       Date:  2016-09-30       Impact factor: 13.281

10.  Design strategies for chemical-stimuli-responsive programmable nanotherapeutics.

Authors:  Muhammad Gulfam; Fitsum Feleke Sahle; Tao L Lowe
Journal:  Drug Discov Today       Date:  2018-10-05       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.